Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hooper

Showing results (141-150 of 631) with videos related to

Pageof 64
Sort By:
Antimicrobial Agents and Chemotherapy|March 26, 2003
Activity of and resistance to moxifloxacin in Staphylococcus aureusDilek Ince, Xiamei Zhang, David C Hooper
Australian Veterinary Journal|May 2, 2007
Ganglioneuritis causing high mortalities in farmed Australian abalone (Haliotis laevigata and Haliotis rubra)C Hooper, P Hardy-Smith, J Handlinger
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Identification of a Staphylococcus aureus Efflux Pump Regulator Using a DNA-Protein Affinity TechniqueQue Chi Truong-Bolduc, David C Hooper
Antimicrobial Agents and Chemotherapy|January 27, 2006
Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolonesJacob Strahilevitz, Ari Robicsek, David C Hooper
Protein Expression and Purification|November 18, 2005
An improved expression plasmid for affinity purification of Staphylococcus aureus gyrase A subunitJacob Strahilevitz, Yoshikuni Onodera, David C Hooper
Journal of Bacteriology|January 14, 2000
Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory systemB Fournier, R Aras, D C Hooper
Seminars in Plastic Surgery|March 18, 2024
A Historical Review of Racial, Ethnic, and Gender Diversity in Plastic Surgery at the University of MichiganJulien J S Levy, Rachel C Hooper
Journal of Bacteriology|February 6, 2007
The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureusQue Chi Truong-Bolduc, David C Hooper
Antimicrobial Agents and Chemotherapy|August 1, 1996
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureusE Y Ng, M Trucksis, D C Hooper
Current Molecular Medicine|August 22, 2006
Cardiac biomarkers for the prediction and diagnosis of atherosclerotic disease and its complicationsM D Weinberg, W C Hooper, G Dangas
Pageof 64

Showing results (141-150 of 631) with videos related to

Sort By:
Pageof 64
Antimicrobial Agents and Chemotherapy|March 26, 2003
Activity of and resistance to moxifloxacin in Staphylococcus aureusDilek Ince, Xiamei Zhang, David C Hooper
Australian Veterinary Journal|May 2, 2007
Ganglioneuritis causing high mortalities in farmed Australian abalone (Haliotis laevigata and Haliotis rubra)C Hooper, P Hardy-Smith, J Handlinger
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Identification of a Staphylococcus aureus Efflux Pump Regulator Using a DNA-Protein Affinity TechniqueQue Chi Truong-Bolduc, David C Hooper
Antimicrobial Agents and Chemotherapy|January 27, 2006
Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolonesJacob Strahilevitz, Ari Robicsek, David C Hooper
Protein Expression and Purification|November 18, 2005
An improved expression plasmid for affinity purification of Staphylococcus aureus gyrase A subunitJacob Strahilevitz, Yoshikuni Onodera, David C Hooper
Journal of Bacteriology|January 14, 2000
Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory systemB Fournier, R Aras, D C Hooper
Seminars in Plastic Surgery|March 18, 2024
A Historical Review of Racial, Ethnic, and Gender Diversity in Plastic Surgery at the University of MichiganJulien J S Levy, Rachel C Hooper
Journal of Bacteriology|February 6, 2007
The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureusQue Chi Truong-Bolduc, David C Hooper
Antimicrobial Agents and Chemotherapy|August 1, 1996
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureusE Y Ng, M Trucksis, D C Hooper
Current Molecular Medicine|August 22, 2006
Cardiac biomarkers for the prediction and diagnosis of atherosclerotic disease and its complicationsM D Weinberg, W C Hooper, G Dangas
Pageof 64